Recent Reports

ICER’s revised Evidence Report assessing the comparative clinical effectiveness and value of anabolic therapies for osteoporosis.

View More on this Topic

The New Evidence Update will be released in two parts. This portion covers new information about the comparative clinical effectiveness of evolocumab that has been released since the original ICER report on PCSK9 inhibitors was issued in 2015, including an analysis of newly-released evidence from the FOURIER trial. In the coming months, ICER will release an updated economic analysis based on the FOURIER trial data that will include a revised valuebased price benchmark for evolocumab.

View More on this Topic

Final Report and Meeting summary for ICER’s review of crisaborole and dupilumab for atopic dermatitis.

View More on this Topic

ICER’s briefing paper seeks to understand the commercial, regulatory, and reimbursement environments for rare drug development, and compares methods used by academic researchers and international agencies to evaluate the long-term value of drugs for rare conditions.

View More on this Topic

ICER’s Draft Evidence Report on treatments for abuse-deterrent formulations of opioids, open to public comment until June 2, 2017. For more information on submitting a public comment, please visit our stakeholder engagement page.

View More on this Topic

Materials

ICER

Final Value Assessment Framework: Updates for 2017-2019

Midwest CEPAC

Voretigene neparvovec: Open Input Period

ICER

PCSK9 Inhibitors: New Evidence Update

Midwest CEPAC

Atopic Dermatitis: Report-at-a-Glance

ICER

Orphan Drug Assessment and Pricing Summit: Summit Pre-Reading

ICER

Choosing Wisely: Preoperative Stress Testing

ICER

Choosing Wisely: Percutaneous Coronary Intervention for Stable Ischemic Heart Disease

ICER

Choosing Wisely: Imaging for Uncomplicated Headache

ICER

Choosing Wisely: Imaging for Non-specific Low Back Pain

ICER

Choosing Wisely: Carotid Artery Stenosis Screening in Asymptomatic Patients

ICER

Choosing Wisely: Pap Testing

CTAF

Osteoporosis: Model Analysis Plan